Medicine

SAGE Therapeutics Options Traders Don't Buy Depression Drug Breakout

SAGE Therapeutics Options Traders Don't Buy Depression Drug Breakout

Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 116.45% since December 7, 2016 and is uptrending.

"There are now significant gaps in the disease management of depression and our development goal at Sage is to change patients' expectations by transforming the treatment landscape for MDD", said Steve Kanes, M.D., Ph.D., chief medical officer of Sage Therapeutics. (NASDAQ:SAGE) hit a new 52-week high and has $164.39 target or 5.00% above today's $156.56 share price. The 1-year high was reported on Dec, 7 by Barchart.com. They set a "buy" rating and a $104.00 target price for the company.

The stock increased 74.90% or $68.83 during the last trading session, reaching $160.73. About 3.06M shares traded or 259.64% up from the average.

Several brokerages have recently weighed in on SAGE. It has outperformed by 99.75% the S&P500. (NASDAQ:SAGE). Tiaa Cref Inv Mgmt Ltd Llc reported 122,554 shares. After $-1.97 actual earnings per share reported by Sage Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 1.52% negative EPS growth. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. Therefore 88% are positive. Sage Therapeutics has a consensus rating of "Buy" and an average price target of $105.14. $96.67's average target is -38.25% below currents $156.56 stock price.

What Are Analysts Opinions On Ctrip.com International Ltd. (CTRP)
The difference between the expected and actual EPS was $0.17/share, which represents an Earnings surprise of 70.8%. The stock of The Allstate Corporation (NYSE:ALL) has "Hold" rating given on Monday, August 10 by Deutsche Bank.

SAGE has been the topic of several other research reports. Chardan Capital upgraded SAGE Therapeutics from a sell rating to a neutral rating and set a $60.00 price target on the stock in a report on Tuesday, February 14th. Northern Corp stated it has 0.01% in Sage Therapeutics, Inc. (NASDAQ:SAGE) earned "Buy" rating by H.C. Wainwright on Thursday, June 23. As per Wednesday, March 30, the company rating was initiated by Goldman Sachs. As per Tuesday, September 12, the company rating was maintained by Needham. Stifel Nicolaus maintained Sage Therapeutics, Inc. The stock presently has a consensus rating of Buy and a consensus target price of $78.92. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The company's market cap is $2.58 billion. "There has been little innovation in the discovery and development of treatments for depression in the last two decades". It now has negative earnings.

Sage Therapeutics (NASDAQ:SAGE) is up 52% premarket on light volume in response to its announcement of positive results from a Phase 2 clinical trial assessing SAGE-217 for the treatment of adult patients with moderate-to-severe major depressive disorder (MDD), a Fast Track indication in the U.S. NasdaqGM:SAGE is -0.071077. Earnings Yield helps investors measure the return on investment for a given company. Its down 0.13, from 1.11 in 2017Q1.

In addition to ROA, there are a number of additional ratios and Quant signals available to investors in order to decipher if the shares are a good fit for their portfolio. Alps Advisors reported 0.02% stake.

Watching some historical volatility numbers on shares of Verastem, Inc. Sage Therapeutics earned a coverage optimism score of 0.12 on Accern's scale. (NASDAQ:SAGE). 125,000 are owned by Point72 Asset Mgmt Ltd Partnership. Bancorporation Of Montreal Can, Ontario - Canada-based fund reported 204 shares. (NasdaqGM:SAGE) is -0.026146. This percentage is calculated by adding the dividend yield plus the percentage of shares repurchased. (NASDAQ:SAGE). Raymond James Advsr has invested 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). State Board Of Administration Of Florida Retirement System owns 12,742 shares for 0% of their portfolio.


  • Nabors Industries Ltd. (NBR)

    This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell. To evaluate a picky trading instrument, an investment sector or the market as a whole is termed as Stock Analysis.
    New England Patriots radio commentator cheers on Rob Gronkowski's late hit

    New England Patriots radio commentator cheers on Rob Gronkowski's late hit

    Former Bills safety Aaron Williams expressed similar sentiments on Twitter, saying Buffalo players showed "no clout". The fact that White ended up in concussion protocol was not a factor, according to Vincent.
    Gus Malzahn to remain at Auburn after multi-year contract extension

    Gus Malzahn to remain at Auburn after multi-year contract extension

    Georgia's Kirby Smart got the nod as coach of the year and Auburn quarterback Jarrett Stidham was chosen as newcomer of the year. Whether head coach Gus Malzahn will still be around to lead the way is somewhat debatable.
  • Mining Equipment Market Overview, Growth, Demand and Forecast Research Report to 2021

    Mining Equipment Market Overview, Growth, Demand and Forecast Research Report to 2021

    This report investigates new project feasibility with a goal of enlightening new entrants about the possibilities in this market . Additionally, the report provides Agricultural Equipment Rubber Track manufacturers market position and their website addresses.
    Bitcoin surges past $15000 because why not

    Bitcoin surges past $15000 because why not

    Since the last month, Bitcoin breached the levels of USD 7,000; USD 8,000; USD 9,000; USD 10,000; USD 11,000 and now USD 12,000. Bitcoin was eyeing $13,000 a coin Wednesday morning, less than 12 hours after soaring over $12,000 for the first time.

    What's Real Worth Of Thermo Fisher Scientific Inc. (TMO), Xerox Corporation (XRX)

    Comml Bank Of Montreal Can invested 0.05% in Thermo Fisher Scientific Inc . (NYSE: TMO ) are 30.31% since the start of 2016. To fully grasp the existing nature of the stock, a trader will need to know the company's stock price to its revenues.
  • Sears Hldgs Corp (SHLD): Stock to Follow

    Sears Hldgs Corp (SHLD): Stock to Follow

    During current year the company's forecasts over growth are -11.6% while for the next year analysts' growth estimation is -19.4%. Currently, 3.00% of Centene Corporation (NYSE:CNC) are owned by insiders with 93.03% six-month change in the insider ownership.
    Israel says F-35 stealth fighter jets operational

    Israel says F-35 stealth fighter jets operational

    This is another expression of the cooperation and the special strategic relationship between Israel and the United States. The American pilots that come to us didn't experience that because they fly there, in Arizona, in Florida.

    Rhumbline Advisers Raises Position in Fluor Corporation (FLR)

    The construction company reported $0.57 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.67 by $0.10. KeyCorp reaffirmed a "buy" rating and issued a $50.00 price target on shares of Fluor in a report on Friday, September 22nd.
  • Huntsman (HUN) Shares Gap Down on Insider Selling

    ILLEGAL ACTIVITY WARNING: This article was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. Finally, BidaskClub upgraded shares of Huntsman from a "sell" rating to a "hold" rating in a report on Wednesday, August 23rd.

    How Insiders and Institutions are Trading Newell Brands Inc. (NWL)

    TheStreet lowered shares of Newell Brands from a "b-" rating to a "c+" rating in a research note on Tuesday, November 14th. The stock of Newell Brands Inc . (NASDAQ:COBZ) has "Buy" rating given on Tuesday, October 3 by Keefe Bruyette & Woods.
    China's Foreign Exchange Reserves Continue To Rise

    China's Foreign Exchange Reserves Continue To Rise

    China's foreign-exchange reserves increased for a 10th month in November amid continued stability in the yuan . Economists polled by The Wall Street Journal had expected a rise of $13 billion.